News from across the Regional Innovation Centres

We have gathered news from all the regional innovation centres (RICs) in Ontario. Be sure to connect with your local RIC to be a part of your local ecosystem.

The Structure of Salad

Danielle Veneruzzo graduated from university wanting to find a job that matched her skills, that made her feel that her degree was worth something, and that she could excel at. Jelena Psenicnik wanted to expand and diversify her business. She…

Ontario Expanding Economic Opportunity for Entrepreneurs

Ontario Expanding Economic Opportunity for Entrepreneurs New business grant supporting Indigenous, Black and other racialized entrepreneurs March 17, 2022Ministry of Citizenship and Multiculturalism The Ontario government is investing $5 million over two years in a targeted program to help Indigenous,…

Women in Tech Spotlight: Nisha Krithivasan

The third entry in our new Windsor-Essex and Chatham-Kent Women in Tech Spotlight Series. 1. Introduce yourself and your position in the tech industry. (function($) {$("head").append("#dfd-heading-623a13334b7cb .dfd-heading-module {}#dfd-heading-623a13334b7cb .dfd-heading-delimiter {border-bottom-style: solid;width: 100px;border-bottom-width: 10px;border-bottom-color: #70ab37;}#dfd-heading-623a13334b7cb .dfd-heading-delimiter {margin-top: 10px;margin-bottom: 20px;}");})(jQuery); A: I…

iGUIDE to open new headquarters

WATERLOO, ONT., Canada, (February 3, 2022) — iGUIDE – creator of an industry-leading spatial data solution for use in the real estate, insurance, restoration, property management, and affiliated industries — has announced the opening of their new office environment in…

Data Safety Monitoring Board recommends continuation of phase 1/2 clinical trial with Sernova’s Cell Pouch System™ in patients with Type-1 Diabetes

Sernova Corp., a clinical- stage company and leader in regenerative medicine cell therapeutics, is pleased to announce that the Data Safety Monitoring Board (“DSMB”) has completed the third annual review of Sernova’s ongoing Phase 1/2 clinical study “Safety, Tolerability and…

This website uses cookies to save your preferences, and track popular pages. Cookies ensure we do not require visitors to register, login, or share any identity information.